Young diabetics remain at higher risk of acute myocardial infarction with cannabis use disorder

Desai, Rupak; Jain, Akhil; Patel, Bhavin; Sadolikar, Ashish; Alukal, Thomas

doi:10.1016/j.ejim.2022.09.026

European Journal of Internal Medicine

2023

DOI: 10.1016/j.ejim.2022.09.026

|View full text |Cite

Young diabetics remain at higher risk of acute myocardial infarction with cannabis use disorder

Rupak Desai¹,

Akhil Jain²,

Bhavin Patel³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Another nationwide study reported two times higher odds of all-cause in-hospital mortality among cannabis users with the background history of pulmonary hypertension ( 8 ). On the other hand, studies by Desai et al and Johnson-Sasso et al , though reported higher acute MI, they reported that cannabis use was not associated with an increased risk of adverse short-term in-hospital outcomes following acute MI ( 9 , 10 ). These differences in shorter outcomes may be related to the proven and established efficacies of the MI treatment than stroke management.…”

mentioning

confidence: 91%

Effects of cannabis on in-patient diabetic patients with prior revascularized (PCI and/or CABG) myocardial infarction and health care service utilization

Desai¹,

Khehra²,

Padda³

et al. 2023

Ann Transl Med

View full text Add to dashboard Cite

The legalization of cannabis for recreational and medical purposes has contributed to its increased popularity and caused concern in the United States (US) (1). Cannabis users have been reported to have an increase in hospitalizations and emergency room visits for acute myocardial infarctions (MI) and other adverse effects of cannabis (2,3). The available literature supports the poor hospital outcomes following percutaneous coronary intervention (PCI), and increased risk for Major Adverse Cardiac and Cerebrovascular Events (MACCE), resulting in increased healthcare utilization and costs in patients having chronic cannabis use, and prior diabetes, revascularization procedures, chronic lung disease, concurrent tobacco use, hypertension, and dyslipidemia exhibited (4). We conducted propensity score-matched analysis to assess and better understand the implications of cannabis use disorder (CUD) on hospitalized patients with diabetes mellitus (DM) and prior revascularized MI, i.e., either PCI or coronary artery bypass graft (CABG), using a publicly available US population representative hospitalization sample database.We identified hospitalizations with type 1 or type 2 DM, prior revascularized MI (PCI or CABG), and CUD from the National Inpatient Sample (NIS) database between October 2015 and December 2017 using previously validated ICD-10 codes. Propensity score analysis with 1:1 matching was conducted using a caliper width of 0.2 and near neighbor match adjusting age, sex, race, type of admission (elective/non-elective), payer status, median household income quartile of patient's zip code, hospital bed size, location/teaching status and region to identify two cohorts, CUD positive (CUD+, n=190) and CUD negative (CUD−, n=190). The CUD+ and CUD− groups were compared for comorbidities and in-hospital outcomes. The age groups in this study were 18-44, 45-64, and ≥65 years. MACCE, consisting of all-cause mortality, acute MI, cardiac arrest and stroke, and subsequent revascularization, were the primary outcomes in the analysis. Multivariable logistic regression model to assess MACCE with vs. without CUD was adjusted for age at admission, sex, race, hypertension, hyperlipidemia, obesity, renal failure, coagulopathy, congestive heart failure, chronic pulmonary disease, depression, drug abuse, alcohol abuse, and tobacco use disorder. C-statistics was performed for the fitness of model. The median duration of hospital stays, and charges were the secondary outcomes. We used Mann-Whitney U test and Pearson's Chi square test for P value statistics for continuous and categorical variables respectively. P value of less than 0.05 was taken as significant statistical association.In this nationwide propensity-matched analysis (1:1), 380 DM patients with previous MI and revascularizations were stratified into CUD+ and CUD− cohorts with Letter to the Editor

show abstract

mentioning

confidence: 91%

Effects of cannabis on in-patient diabetic patients with prior revascularized (PCI and/or CABG) myocardial infarction and health care service utilization

Desai¹,

Khehra²,

Padda³

et al. 2023

Ann Transl Med

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Young diabetics remain at higher risk of acute myocardial infarction with cannabis use disorder

Cited by 1 publication

References 12 publications

Effects of cannabis on in-patient diabetic patients with prior revascularized (PCI and/or CABG) myocardial infarction and health care service utilization

Effects of cannabis on in-patient diabetic patients with prior revascularized (PCI and/or CABG) myocardial infarction and health care service utilization

Contact Info

Product

Resources

About